Evidence map›Paper›PMID 29285648›Full record

Trial reportEuropean journal of pediatrics2018

Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain.

Amparo Escribano Montaner, Juan García de Lomas, José Ramón Villa Asensi, Oscar Asensio de la Cruz, Olga de la Serna Blázquez, Mikel Santiago Burruchaga, Pedro Mondéjar López, Alba Torrent Vernetta, Yang Feng, Melissa K Van Dyke and 4 more

2 registry-linked trialsOpen access · hybridAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in European journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02838407 nacompletednot on this map

Identification and Characterization of Bacteria in the Lower Airways of Children Aged ≥ 6 Months to < 6 Years With Suspected Lower Respiratory Tract Infections (LRTI) in Spain.

TypeinterventionalSponsorGlaxoSmithKlineRan2013 to 2015Enrolled197ConditionsInfections, StreptococcalArmsBAL fluid sampling, Nasopharyngeal swab sampling
NCT07232550 recruitingnot on this mapstarted 2026, after this paper: background citation

Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation - a Multi-cohort, Multi-center Study

TypeobservationalSponsorMedical University of WarsawRan2026 to 2035Enrolled160ConditionsAsthma in Children, Protracted Bacterial Bronchitis, Chronic CoughArmsfiberoptic bronchoscopy, blood sample collection, Respiratory functional tests, Sputum culture
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Molecular analysis of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Amparo Escribano MontanerPediatric Pneumology and Cystic Fibrosis Unit, University Clinic Hospital of Valencia, University of Valencia, Av. de Blasco Ibáñez, 13, 46010, Valencia, Spain.
Juan García de LomasDepartment of Microbiology, School of Medicine and University Hospital, University of Valencia, Av. de Blasco Ibañez 17, 46010, Valencia, Spain.
José Ramón Villa AsensiPediatric Department, Niño Jesús University Hospital for Children, Calle Menéndez Pelayo, 65, 28009, Madrid, Spain.
Oscar Asensio de la CruzPediatric Pulmonology Unit, University Hospital Parc Tauli de Sabadell, Parc Taulí, 1, 08208, Sabadell, Barcelona, Spain.
Olga de la Serna BlázquezPediatric Department, Hospital La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain.
Mikel Santiago BurruchagaPediatric Pneumology and Cystic Fibrosis Unit, Cruces University Hospital, Plaza de Cruces, S/N, 48903, Baracaldo, Vizcaya, Spain.
Pedro Mondéjar LópezPediatric Pulmonology and Cystic Fibrosis Unit, Virgen of Arrixaca University Hospital, Ctra. Madrid-Cartagena, s/n, 30120, El Palmar, Murcia, Spain.
Alba Torrent VernettaPaediatric Pulmonology and Cystic Fibrosis Unit, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Yang FengNingyang Group Co., Limited, C/O GSK, Wavre, Belgium.
Melissa K Van DykeGSK, Collegeville, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA.
Janet ReyesGSK, Parque Tecnológico de Madrid, Calle de Severo Ochoa, 2, 28760, Tres Cantos, Madrid, Spain.
Pilar Garcia-CorbeiraGSK, Parque Tecnológico de Madrid, Calle de Severo Ochoa, 2, 28760, Tres Cantos, Madrid, Spain.
Carla A TalaricoGSK, Av. Fleming 20, 1300, Wavre, Belgium. carla.a.talarico@gsk.com.
EPI-Strep-064 study group
Universitat de València · ESGlaxoSmithKline (Belgium) · BEHospital Universitario La Paz · ESVall d'Hebron Hospital Universitari · ESDeleted InstitutionHospital de Cruces · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This cross-sectional study assessed the prevalence of bacteria isolated from Spanish children with suspected chronic lower respiratory tract infection (LRTI) for whom bronchoalveolar lavage (BAL) was indicated. BAL fluid (BALF) was collected from 191 children (aged ≥ 6 months to < 6 years, with persistent or recurrent respiratory symptoms, non-responders to usual treatment) and cultured. Nasopharyngeal swabs (NPSs) were also obtained and cultured to assess concordance of BALF and NPS findings in the same patient. Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis were identified from BALF with a bacterial load indicative of infection (> 10

conclusionS. pneumoniae, NTHi, and M. catarrhalis were the main bacteria detected in BALF and NPS. Children with suspected chronic LRTI may benefit from a vaccine protecting against NTHi. What is Known: • Chronic lower respiratory tract infection (LRTI) in children can cause high morbidity and is a major use of healthcare resources worldwide. Despite this, their etiology or potential preventive measures are poorly assessed. • Bronchoalveolar lavage can be used to determine bacterial etiology of chronic LRTI. What is New: • We used conventional and molecular techniques to show that Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis were present in the LRT of Spanish children with suspected chronic LRTI • Concordance between isolates from bronchoalveolar lavage fluid and nasopharyngeal swabs was low, suggesting that samples from the upper respiratory tract could not reliably predict the bacterial etiology of suspected chronic LRTI.

Indexed as

Bronchoalveolar LavageBronchoalveolar Lavage FluidChildChild, PreschoolChronic DiseaseCross-Sectional StudiesFemaleHaemophilus InfectionsHaemophilus influenzaeHumansInfantMaleMoraxella catarrhalisMoraxellaceae InfectionsPneumococcal InfectionsPneumonia, BacterialBronchoalveolar lavageChildrenChronic lower respiratory tract infectionNasopharyngeal colonizationNon-typeable Haemophilus influenzaeStreptococcus pneumoniae

Identifiers

PMID29285648
PMCPMC5758651
OpenAlexW2781148362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.